Mepolizumab simultaneously improves clinical outcomes in severe CRSwNP and asthma in the synapse study: Focus on global airway disease

Category Primary study
ConferenceEuropean Academy of Allergy and Clinical Immunology Hybrid Congress
Year 2024
This article has no abstract
Epistemonikos ID: dac80a02c4ce2be49eb5515d22caab39f2ba4dba
First added on: Feb 16, 2026